The characteristic pathological changes of AD (i.e., β-amyloid deposition and pathological tau protein) distinguish AD from other neurodegenerative diseases (69–71), and its biomarkers are proxies for AD neuropathologic changes (24). Here, YWHAQ is linked to Alzheimer disease.